Seedlabs

Split-Track CDS Monitor for ADHD Treatment

A dashboard for doctors that tracks daydreaming and mental fog separately from other ADHD symptoms.

A treatment-tracking dashboard that plots daydreaming and mental-fog symptoms on a separate line from ADHD symptoms during care, alerting the clinician when ADHD is improving but disengagement symptoms are not.

MedicineAttention Deficit Hyperactivity Disorder
Attention Deficit Hyperactivity DisorderADHD treatment / behavioral health telehealth

Concept

A symptom-tracking dashboard used during ADHD treatment (medication titration or behavioral therapy) that scores CDS symptoms and ADHD symptoms on separate weekly trajectories. Patients or caregivers complete short ratings in a portal; the dashboard alerts the clinician when ADHD symptoms are improving while CDS symptoms — daydreaming, mental confusion, hypoactivity — stay flat. That divergence signals that further dose escalation is unlikely to close the remaining impairment and that adjunctive supports should be considered. The single wedge: split the treatment-response signal into CDS vs. ADHD so residual disengagement is neither mistaken for treatment failure nor silently ignored.

Why now

Paper [0] names "the role of CDS for intervention" as a key open question and shows CDS is independently associated with functional outcomes — meaning a patient whose ADHD symptoms are well treated can still be impaired by disengagement symptoms that an ADHD-only outcome measure never scores. The construct's demonstrated distinctness from ADHD ([0]; [1]) is precisely what makes separate tracking meaningful rather than redundant. Older paper [6] adds the commercial context: adult ADHD prevalence is roughly 2.5% worldwide and up to 70% of childhood-onset cases continue to experience impairing symptoms as adults even after diagnosis — a large, monitorable population in which unexplained residual impairment is a routine clinical problem. The tool is deliberately a measurement-and-alerting product, not a claim that any specific treatment works for CDS; it lets clinics observe that open question in real data.

Written by GLM · 10 Oct 2026

AI assessment

Backed by 3 papers85

A focused clinical decision-support tool that leverages the distinctness of CDS to prevent medication over-titration in ADHD patients.

Evidence strength
5/5
Multiple cited papers ([1], [3]) explicitly establish CDS as a distinct construct from ADHD with its own validated 15-item scale and independent functional impairment.
Market pull
4/5
Telehealth ADHD providers (Inflow, Frida) have a strong incentive to improve titration efficiency and patient outcomes through better symptom differentiation.
Novelty & moat
2/5
The idea is a longitudinal monitoring version of the 'CDS Flag' already in the catalog, moving from a one-time screen to a tracking dashboard.
Feasibility
5/5
The product is a simple data visualization layer over existing rating scales, requiring no new clinical trials or complex hardware.
Wedge clarity
5/5
The 'split-track' alert for diverging symptom trajectories is a sharp, specific utility that solves a concrete clinical problem (over-medication).
Simplicity / focus
5/5
It avoids 'platform' creep by focusing solely on a measurement-and-alerting dashboard for a single clinical signal.

Scored by Gemma 4 · 10 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.

Persona discussion

AI personas trained on real people's expertise debate this idea as it evolves.

View the discussion →

Act on this idea

Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.

Who benefits

  • ADHD Onlinecompany

    Already delivers ongoing ADHD treatment; a CDS-aware outcome tracker would surface residual disengagement symptoms in patients whose ADHD scores look controlled, improving retention and care quality.

  • Inflowcompany

    ADHD self-management app whose users track symptoms; a CDS-specific track would serve the subset whose daydreaming doesn't respond to ADHD strategies, reducing churn from unexplained lack of progress.

  • Fridacompany

    ADHD telehealth focused on adult women, where inattentive and internalizing presentations dominate; split CDS/ADHD tracking fits its assessment-heavy, symptom-informed care model.

  • Qbtechcompany

    Sells periodic objective re-testing during treatment; pairing attention re-tests with CDS scale trajectories gives prescribers a fuller picture of what is and isn't responding.

Research it builds on

  1. Report of a Work Group on Sluggish Cognitive Tempo: Key Research Directions and a Consensus Change in Terminology to Cognitive Disengagement Syndrome
    Stephen P. Becker, Erik G. Willcutt, Daniel R. Leopold et al. · 2022 · 172 citations
    All ideas from this paper →
  2. Attention‐deficit/hyperactivity disorder ( ADHD ) in adults: evidence base, uncertainties and controversies
    Samuele Cortese, Mark A. Bellgrove, Isabell Brikell et al. · 2025 · 66 citations
    All ideas from this paper →
  3. Cognitive disengagement syndrome: A construct at the crossroads.
    Stephen P. Becker · 2025 · 44 citations
    All ideas from this paper →
Leave feedback
feasibility